Thousands of Bottles of Popular Blood Pressure Medication Recalled Across the U.S.

Today ^ | June 26, 2026 | Caroline Kee

[Red Badger]

More than 11,000 bottles of chlorthalidone have been recalled after testing revealed potential issues which may affect the drug’s effectiveness, the FDA says.

Thousands of bottles of a popular blood pressure medication have been recalled nationwide due to a potential manufacturing issue that may affect how well the drug works.

According to the U.S. Food and Drug Administration, more than 11,400 bottles of prescription chlorthalidone pills are affected.

On June 5, the drug’s manufacturer, India-based Inventia Healthcare Limited, initiated a voluntary recall of certain lots of its 25-mg chlorthalidone tablets. The recalled 100-count and 1,000-count bottles were distributed across the U.S. by Rising Pharma Holdings, Inc., of New Jersey.

The recall was issued after testing revealed that certain lots of the medication “failed dissolution specifications,” per the FDA. This means that the tablets may not dissolve in the body as intended, which could impact their effectiveness.

On June 22, the FDA classified the recall as a moderate hazard or “Class II,” which is defined as a situation where use of the recalled product may cause temporary or medically-reversible adverse health effects, the agency explains.

Chlorthalidone is a common diuretic medication used to treat high blood pressure and fluid retention, per Medline Plus. It works by helping the kidneys get rid of excess water and salt in the body and excrete them through urine.

If you take prescription blood pressure medication, it may be worth checking the label on the bottle.

Which Blood Pressure Pills Were Recalled? Approximately 11,460 bottles of prescription-only chlorthalidone were recalled, per the FDA.

The tablets were manufactured by Inventia Healthcare Limited, based in Mumbai, India. Recalled bottles have a specific NDC (National Drug Code) and batch number on the label.

The blood pressure medication affected by this recall includes:

Chlorthalidone Tablets, USP, 25 mg (100 count)

NDC: 64980-599-01 Batch: RISA24001 Expiration date: 04/2027 Chlorthalidone Tablets, USP, 25 mg (1,000 count)

NDC: 64980-599-10 Batch: RISB24002 Expiration date: 04/2027 The recalled bottles were distributed nationwide by Rising Pharma Holdings, Inc., in East Brunswick, New Jersey.

What to Do If You Have Recalled Medication The FDA has not yet released specific instructions for patients.

Anyone who takes 25-mg tablets of chlorthalidone should consider checking the label on the bottle to see if it matches the recalled product description.

If you believe your medication is affected in this recall, contact your doctor or pharmacist immediately to discuss next steps.

Always consult with a medical professional before discontinuing prescription medication. Abruptly stopping taking blood pressure medication can have side effects and serious health risks, per the American Heart Association.

This is the second recall of a commonly-prescribed blood pressure medication to occur in less than a year.

In October 2025, more than half a million bottles of prazosin hydrochloride were recalled over concerns that the capsules contained unsafe levels of cancer-causing chemicals.

---

TOPICS: Business/Economy; Health/Medicine; Military/Veterans; Society
KEYWORDS: chlorthalidone

[blackdog]

Mmmm-kay.

[CrimsonTidegirl]

I take this medication. Great.

My pharmacy puts all twelve of my meds in a blister pack, so I don’t have a bottle to check.

Thanks for posting this info.